Examples include Ewing’s sarcoma, where an EWS-FLI1 translocation acts as an oncogene; alveolar rhabdomyosarcoma, driven by the PAX3-FOXO1 fusion; and synovial sarcoma, characterised by the SS18-SSX fusion [2]. This evidence concerns the gene SSX2 and synovial sarcoma.